| RPTIX | TRGPX | RPTIX / TRGPX | |
| Total Expense Ratio | 0.63 | 0.65 | 97% |
| Annual Report Gross Expense Ratio | 0.63 | 0.65 | 97% |
| Fund Existence | 11 years | 17 years | - |
| Gain YTD | 2.008 | 2.098 | 96% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 500000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 22.5B | 681M | 3,304% |
| Annual Yield % from dividends | 0.11 | 0.00 | - |
| Returns for 1 year | 0.10 | -6.88 | -1% |
| Returns for 3 years | 2.69 | 12.56 | 21% |
| Returns for 5 years | -19.32 | -31.66 | 61% |
| Returns for 10 years | 38.36 | 10.09 | 380% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FDETX | 30.19 | N/A | N/A |
| Fidelity Advisor Capital Development O | |||
| RYSGX | 69.90 | N/A | N/A |
| Rydex S&P SmallCap 600 Pure Growth A | |||
| CVMRX | 31.08 | N/A | N/A |
| Calvert Emerging Markets Equity R6 | |||
| MCGCX | 23.46 | N/A | N/A |
| BlackRock Advantage Global Investor C | |||
| MRGEX | 19.32 | N/A | N/A |
| Morgan Stanley Inst Emerging Mkts IR | |||